Kymera Therapeutics
(NASDAQ) KYMR
Kymera Therapeutics Financials at a Glance
Market Cap
$7.44B
Revenue (TTM)
$51.47M
Net Income (TTM)
-$315.05M
EPS (TTM)
-$3.57
P/E Ratio
-25.32
Dividend
$0.00
Beta (Volatility)
1.63 (High)
Dividend
$0.00
Beta (Volatility)
1.63 (High)
Price
$90.57
Volume
1,262,295.475
Open
$90.68
Price
$90.57
Volume
1,262,295.475
Open
$90.68
Previous Close
$90.43
Daily Range
$89.18 - $92.47
52-Week Range
$36.65 - $103.00
Estimated Earnings Date
Jul 31, 2026
Dividend
$0.00
Beta (Volatility)
1.63 (High)
Price
$90.57
Volume
1,262,295.475
Open
$90.68
Previous Close
$90.43
Daily Range
$89.18 - $92.47
52-Week Range
$36.65 - $103.00
Estimated Earnings Date
Jul 31, 2026
KYMR News
KYMR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kymera Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
238
CEO
Nello Mainolfi, PhD
Website
www.kymeratx.comHeadquarters
Watertown, MA 02472, US
KYMR Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-7%
Net Income Margin
-6%
Return on Equity
-27%
Return on Capital
-22%
Return on Assets
-19%
Earnings Yield
-3.95%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.44B
Shares Outstanding
82.26M
Volume
1.26M
Avg. Volume
589.97K
Financials (TTM)
Gross Profit
$39.20M
Operating Income
-$349.40M
EBITDA
-$303.06M
Operating Cash Flow
-$232.89M
Capital Expenditure
-$1.45M
Free Cash Flow
-$234.34M
Cash & ST Invst.
$848.28M
Total Debt
$82.25M
Kymera Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$34.37M
+55.5%
Gross Profit
$34.37M
+55.5%
Gross Margin
100.00%
N/A
Market Cap
$7.44B
N/A
Market Cap/Employee
$35.76M
N/A
Employees
208
N/A
Net Income
-$69.23M
-5.6%
EBITDA
-$67.15M
-5.8%
Quarterly Fundamentals
Total Cash
$650.93M
+40.5%
Total Debt
$80.47M
-6.8%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$66.74M
-8.7%
Short Term Debt
$13.73M
+3.7%
Return on Assets
-18.88%
N/A
Return on Invested Capital
-22.36%
N/A
Free Cash Flow
-$89.27M
-12.1%
Operating Cash Flow
-$88.84M
-12.2%